Tender detail

Non-exclusive medicine rebate agreement for pamidronic acid

Summary

DAK-Gesundheit intends to conclude non-exclusive medicine rebate agreements with interested pharmaceutical companies for medicines containing pamidronic acid (ATC M05BA03), as specified in the contract annex. The agreements are scheduled to run from 1 January 2027 to 31 December 2028, with one optional 12-month extension, and will end automatically when an exclusive agreement for the active ingredient takes effect.

Reference number
1c3a519d-9288-4d50-96cd-48694868051b
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2029-11-05
Status
Open
Contract subject
Supplies
Estimated value
1,00 EUR
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.